rs367906861
Variant names:
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_032968.5(PCDH11X):c.1011A>G(p.Ala337Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0022 ( 1 hom., 30 hem., cov: 14)
Exomes 𝑓: 0.00030 ( 1 hom. 57 hem. )
Consequence
PCDH11X
NM_032968.5 synonymous
NM_032968.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.147
Publications
0 publications found
Genes affected
PCDH11X (HGNC:8656): (protocadherin 11 X-linked) This gene belongs to the protocadherin gene family, a subfamily of the cadherin superfamily. The encoded protein consists of an extracellular domain containing 7 cadherin repeats, a transmembrane domain and a cytoplasmic tail that differs from those of the classical cadherins. The gene is located in a major X/Y block of homology and its Y homolog, despite divergence leading to coding region changes, is the most closely related cadherin family member. The protein is thought to play a fundamental role in cell-cell recognition essential for the segmental development and function of the central nervous system. Disruption of this gene may be associated with developmental dyslexia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2014]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant X-91877251-A-G is Benign according to our data. Variant chrX-91877251-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 724999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.147 with no splicing effect.
BS2
High Hemizygotes in GnomAd4 at 30 gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00219 AC: 201AN: 91806Hom.: 1 Cov.: 14 show subpopulations
GnomAD3 genomes
AF:
AC:
201
AN:
91806
Hom.:
Cov.:
14
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000783 AC: 81AN: 103477 AF XY: 0.000397 show subpopulations
GnomAD2 exomes
AF:
AC:
81
AN:
103477
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000297 AC: 291AN: 981124Hom.: 1 Cov.: 19 AF XY: 0.000199 AC XY: 57AN XY: 286872 show subpopulations
GnomAD4 exome
AF:
AC:
291
AN:
981124
Hom.:
Cov.:
19
AF XY:
AC XY:
57
AN XY:
286872
show subpopulations
African (AFR)
AF:
AC:
233
AN:
23805
American (AMR)
AF:
AC:
15
AN:
31682
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
18137
East Asian (EAS)
AF:
AC:
0
AN:
28317
South Asian (SAS)
AF:
AC:
0
AN:
49006
European-Finnish (FIN)
AF:
AC:
0
AN:
37019
Middle Eastern (MID)
AF:
AC:
4
AN:
3735
European-Non Finnish (NFE)
AF:
AC:
6
AN:
747252
Other (OTH)
AF:
AC:
33
AN:
42171
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
12
24
37
49
61
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00219 AC: 201AN: 91843Hom.: 1 Cov.: 14 AF XY: 0.00174 AC XY: 30AN XY: 17231 show subpopulations
GnomAD4 genome
AF:
AC:
201
AN:
91843
Hom.:
Cov.:
14
AF XY:
AC XY:
30
AN XY:
17231
show subpopulations
African (AFR)
AF:
AC:
194
AN:
24872
American (AMR)
AF:
AC:
3
AN:
7835
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
2331
East Asian (EAS)
AF:
AC:
0
AN:
2931
South Asian (SAS)
AF:
AC:
0
AN:
1627
European-Finnish (FIN)
AF:
AC:
0
AN:
3915
Middle Eastern (MID)
AF:
AC:
0
AN:
202
European-Non Finnish (NFE)
AF:
AC:
2
AN:
46363
Other (OTH)
AF:
AC:
2
AN:
1166
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
9
17
26
34
43
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Mar 29, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.